Answers are grounded in this paper and cite their sources.
Secondary dengue infections are associated with an increased risk of severe disease, mainly due to antibody-dependent enhancement. However, the temporal changes in physiological markers that distinguish primary from secondary infections are not well defined. This study aimed to analyze hematological and biochemical parameters throughout different stages of the disease in dengue patients, stratified by prior infection status, during Bangladesh’s 2024 outbreak. A prospective observational study was conducted at a tertiary hospital in Chattogram, Bangladesh, with 137 dengue-confirmed patients from July to October 2024. Participants were categorized based on anti-dengue IgG serostatus: secondary (IgG-positive, n = 33) or primary (IgG-negative, n = 40). Key hematological and biochemical markers—including platelet count, hematocrit, neutrophil-to-lymphocyte ratio (NLR), ALT, and AST—were monitored across five disease stages: febrile (Stages 1–2), critical (Stage 3), and early and late recovery (Stages 4–5). Disease severity was classified according to the WHO 2009 guidelines, encompassing dengue with or without warning signs and severe dengue. Appropriate statistical tests were used ( P < 0.05), and data were expressed as medians and interquartile ranges. Optimal cutoff value of NLR = 3.49 was identified by ROC analysis (AUC = 0.903; 95% CI: 0.83–0.97; sensitivity 94%, specificity 78%). A pre-specified clinical cut-off of NLR > 4.0 was also assessed for bedside triage utility (sensitivity 68%, specificity 71%). These two values have separate analytical purposes, one maximizing discriminatory accuracy and the other operational feasibility, and should not be interpreted interchangeably. Serostatus classification relied on a single acute-phase IgG rapid diagnostic test in 73/137 patients (53%); this approach carries inherent misclassification risk arising from the kinetics of IgG seroconversion, with expected non-differential bias attenuating observed between-group differences toward the null. Distinct physiological profiles emerged between secondary and primary infections. Secondary cases showed a 42% lower platelet count at presentation (88,000 vs. 152,000/µL; P = 0.008), with biphasic recovery including a rebound in Stage 2 and prolonged thrombocytopenia through Stage 5. The NLR trends diverged: secondary infections displayed an initial rise (median 5.2) followed by a 46% decrease at Stage 2 ( P = 0.0001), while primary infections remained relatively stable (~ 3.0). An NLR > 4.0 correctly identified secondary infections with 68% sensitivity and 71% specificity. Liver involvement was more severe in secondary infections, with AST levels three times higher (524 vs. 168 U/L; P = 0.001). Approximately 62% of secondary cases had AST ratios above 2.0, indicating mitochondrial injury. Despite differences in platelet counts, NLR, and liver enzymes, hematocrit patterns were similar across groups. Older adults, especially those over 40, showed prolonged thrombocytopenia and heightened inflammatory markers, indicating increased vulnerability. Our findings are consistent with immunological memory shaping serostatus-dependent dengue clinical trajectories through mechanisms that may extend beyond classical ADE; however, this study did not directly measure viral load, serotype, cytokine profiles, or immune effector function, and all mechanistic interpretations are therefore speculative. These hypothesis-generating findings support the potential value of IgG serostatus in guiding personalized monitoring, particularly in populations with rising seroprevalence, including the elderly, pending prospective validation. Not applicable.
No takes yet. Share an insight, caveat, or question.
Chowdhury et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: